The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO)

Published on Jan 1, 2013in Diabetes and Vascular Disease Research2.707
· DOI :10.1177/1479164112444640
Kazutoshi Murakami14
Estimated H-index: 14
(Okayama University),
Jun Wada63
Estimated H-index: 63
(Okayama University)
+ 6 AuthorsHirofumi Makino98
Estimated H-index: 98
(Okayama University)
Sources
Abstract
Telmisartan partially activates the peroxisome proliferator-activated receptor γ (PPARγ), which may ameliorate the accumulation of visceral adipose tissues and sensitise insulin action. Nineteen patients with essential hypertension and metabolic syndrome were randomly assigned to receive 40 mg of telmisartan (TELMI group) once daily or 80 mg of valsartan (VAL group) once daily for 24 weeks. The visceral fat area (VFA) measured by computed tomography (CT) was significantly reduced from 150.4±15.5 to 127.7±16.7 cm 2 in the TELMI group (p=0.049). Although VFA was also reduced in the VAL group from 169.8±14.8 to 155.3±14.8 cm 2 , the change was not significant (p=0.173). There were no significant changes in body weight, body mass index (BMI), waist circumference, subdermal fat area (SFA), fasting plasma glucose, and homeostasis model assessment of insulin resistance (HOMA-IR) in comparison to the baseline and follow-up data in both groups. In conclusion, telmisartan may have a benefit in the reduction of visceral adipose tissues in comparison to valsartan.
📖 Papers frequently viewed together
89 Citations
20 Citations
66 Citations
References20
Newest
#1Takashi Kajiya (Kadai: Kagoshima University)H-Index: 10
#2Christopher I. HoH-Index: 8
Last. Theodore W. KurtzH-Index: 67
view all 5 authors...
BackgroundAzilsartan medoxomil is a newly approved angiotensin receptor blocker (ARB) reported to lower 24-h blood pressure more effectively than maximally recommended doses of older ARBs. Although azilsartan is considered to be an unusually potent angiotensin II type 1 (AT1) receptor antagonist, li
43 CitationsSource
#1Sung Yoon Lim (KU: Korea University)H-Index: 3
#2Sun Won Kim (KU: Korea University)H-Index: 7
Last. Dong Joo Oh (KU: Korea University)H-Index: 27
view all 14 authors...
Background and Objectives Angiotensin-receptor blockers (ARBs) have beneficial effects on cardiovascular, metabolic, and inflammatory parameters in addition to controlling blood pressure (BP). However, few comparative clinical studies have been conducted with different ARBs. We compared these effects in patients with uncomplicated hypertension who were receiving telmisartan or valsartan.
7 CitationsSource
#1Gao-zhong HuangH-Index: 3
#2Ye-Hua TangH-Index: 1
Last. Yuan ZhongH-Index: 2
view all 8 authors...
OBJECTIVES To investigate the effects of telmisartan on body fat distribution and insulin sensitivity in patients with hypertension and obesity. METHODS In this prospective, randomized study, outpatients from the Sixth People's Hospital affiliated to Shanghai Jiaotong University, Shanghai, China were treated with telmisartan (n=23), or losartan (n=22) for 16 weeks between December 2009 to January 2011. Parameters such as waist and hip circumference, body mass index, fasting blood glucose, insuli...
20 Citations
#1Shiho Fujisaka (University of Toyama)H-Index: 24
#2Isao Usui (University of Toyama)H-Index: 27
Last. Kazuyuki Tobe (University of Toyama)H-Index: 84
view all 16 authors...
Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization from an inflammatory M1 state to an antiinflammatry M2 state in high-fat-fed mice.
84 CitationsSource
#1Anna Foryst-Ludwig (Charité)H-Index: 20
#2Martin Hartge (Charité)H-Index: 7
Last. Ulrich Kintscher (Charité)H-Index: 44
view all 8 authors...
Background Inflammation of adipose tissue (AT) has been recently accepted as a first step towards obesity-mediated insulin resistance. We could previously show that mice fed with high fat diet (HFD) develop systemic insulin resistance (IR) and glucose intolerance (GI) associated with CD4-positive T-lymphocyte infiltration into visceral AT. These T-lymphocytes, when enriched in AT, participate in the development of fat tissue inflammation and subsequent recruitment of proinflammatory macrophages....
50 CitationsSource
#1Hiroshi Kudo (University of Toyama)H-Index: 6
#2Yutaka Yata (University of Toyama)H-Index: 5
Last. Toshiro Sugiyama (University of Toyama)H-Index: 41
view all 11 authors...
Background/Aims: Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis (NASH) are the hepatic manifestation of metabolic syndrome. However, its therapeutic strategy has not been established. Recently, an angiotensin II type 1 receptor blocker, telmisartan (Tel), has received a great deal of attention as a therapeutic tool for metabolic syndrome. The aim of this study was to investigate the efficacy and mechanisms of Tel on a murine NASH model. Methods: C57BL/6 mice were fed a methi...
74 CitationsSource
#1Ken Sugimoto (Osaka University)H-Index: 36
#2Ludmila KazdovaH-Index: 32
Last. Michal PravenecH-Index: 47
view all 9 authors...
ObjectivesTelmisartan is an angiotensin II receptor blocker and selective modulator of peroxisome proliferator-activated receptor-γ reported to increase energy expenditure and improve glucose and lipid metabolism compared with other angiotensin II receptor blockers. As muscle fatty acid oxidation is
30 CitationsSource
#1Daisuke Chujo (Kanazawa University)H-Index: 7
#2Kunimasa Yagi (Kanazawa University)H-Index: 23
Last. Junji Kobayashi (Kanazawa University)H-Index: 31
view all 10 authors...
Telmisartan Treatment Decreases Visceral Fat Accumulation and Improves Serum Levels of Adiponectin and Vascular Inflammation Markers in Japanese Hypertensive Patients
49 CitationsSource
#1Yutaka MoriH-Index: 19
#2Yohta ItohH-Index: 6
Last. Naoko Tajima (Jikei University School of Medicine)H-Index: 62
view all 3 authors...
Objective To investigate the influence of blockade of the renin-angiotensin system (RAS) on adipocytes, we compared the effect of telmisartan versus valsartan and amlodipine on adipocyte cellularity in the spontaneously type 2 diabetic, obese rat model. Methods Male Otsuka Long Evans Tokushima Fatty rats, 8-week-old, were divided into four groups as follows: valsartan (V) group (10 mg/kg, n = 12), telmisartan (T) group (5 mg/kg, n = 12), amlodipine (A) group (2 mg/kg, n = 12), and control (C) gr...
57 CitationsSource
#1Michio Shimabukuro (University of the Ryukyus)H-Index: 54
#2Hideaki TanakaH-Index: 9
Last. Takeshi ShimabukuroH-Index: 3
view all 3 authors...
BackgroundVisceral fat obesity plays an essential role in the clustering of atherosclerotic multiple risk factors in the metabolic syndrome. Telmisartan, an angiotensin II type 1 receptor blocker, has partial agonistic properties for peroxisome proliferator-activated receptor gamma, which is a key r
89 CitationsSource
Cited By19
Newest
#1Yan Wang (Shanxi Medical University)H-Index: 2
#2Shun Qiao (Shanxi Medical University)H-Index: 2
Last. Jing Yang (Shanxi Medical University)H-Index: 1
view all 7 authors...
Background:Diabetes mellitus, metabolic syndrome, and other obesity-related diseases are characterized by insulin resistance (IR) as a common pathophysiological change and are closely related to cardiovascular disease, which seriously threaten human health. Telmisartan belongs to a group of drugs ca
11 CitationsSource
#1Michael A. J. Ferguson (Boston Children's Hospital)H-Index: 88
Source
#1Juan M. Zolezzi (University of Chile)H-Index: 12
#2Manuel J. Santos (UC: Pontifical Catholic University of Chile)H-Index: 13
Last. Nibaldo C. InestrosaH-Index: 87
view all 6 authors...
Over 25 years have passed since peroxisome proliferators-activated receptors (PPARs), were first described. Like other members of the nuclear receptors superfamily, PPARs have been defined as critical sensors and master regulators of cellular metabolism. Recognized as ligand-activated transcription factors, they are involved in lipid, glucose and amino acid metabolism, taking part in different cellular processes, including cellular differentiation and apoptosis, inflammatory modulation and atten...
36 CitationsSource
#1Bernice Tsoi (St. Joseph's Healthcare Hamilton)H-Index: 7
#2Leo E. Akioyamen (U of T: University of Toronto)H-Index: 6
Last. Daria O'Reilly (St. Joseph's Healthcare Hamilton)H-Index: 32
view all 8 authors...
Background Evidence on the long-term clinical benefits of individual members of angiotensin II receptor blockers is limited given the lack of head-to-head studies. We conducted a network meta-analysis to determine the comparative efficacy of different members within this drug class with respect to outcomes of (i) blood pressure reduction (at 24 and 52 weeks) and (ii) prevention of cardiovascular disease (>104 weeks). Methods A systematic literature review was conducted – Protocol registration: (...
7 CitationsSource
#1Piyush M. Patel (Intas Biopharmaceuticals)H-Index: 46
The cardiovascular and renal disease continuum is a well-established concept describing the emergence and subsequent progressive nature of cardiovascular and renal disease. Several trials have demonstrated the benefits of angiotensin receptor blockers at different stages of the continuum. This review focuses on clinical evidence of telmisartan, generated to date, across all four stages of the cardiovascular and renal disease continuum (i.e. risk factors, subclinical organ damage, overtly manifes...
2 CitationsSource
Source
#1Geun Joo Choi (CAU: Chung-Ang University)H-Index: 13
#2Hyun Min Kim (CAU: Chung-Ang University)H-Index: 10
Last. Jaetaek Kim (CAU: Chung-Ang University)H-Index: 21
view all 4 authors...
AbstractObjectives: Several meta-analyses have confirmed the positive metabolic effects of telmisartan, an angiotensin II receptor blocker that can also act as a partial peroxisome proliferator-activated receptor-γ agonist, compared to those of other angiotensin II receptor blockers. These effects include decreased fasting glucose, glycosylated hemoglobin, interleukin-6, and tumor necrosis factor-α levels. However, no systemic analysis of telmisartan’s effects on body fat distribution has been p...
8 CitationsSource
#2Antonin SkochH-Index: 15
Last. Terezie PelikanovaH-Index: 17
view all 8 authors...
Ectopic lipid accumulation in skeletal muscle is associated with insulin resistance. Telmisartan improves metabolic parameters in type 2 diabetic patients. The aim of our study was to evaluate the in vivo effect of telmisartan on intramyocellular lipid content (IMCL) in subjects with impaired fasting glucose (IFG) by magnetic resonance spectroscopy (MRS). We enrolled 10 subjects with IFG in a cross-over, placebo-controlled, randomized, double-blind trial, treated with 3 weeks of telmisartan (160...
Source
The renin–angiotensin–aldosterone system plays an important role in the pathophysiology of hypertension and is closely related with cardio- and cerebrovascular events and chronic kidney diseases. Each angiotensin receptor blocker (ARB) is important in the treatment of hypertension, according to the results of recent years. This is a practical review of the available evidence on the different benefits of ARBs beyond their blood pressure-lowering effect, with an emphasis on the differences found b...
17 CitationsSource
Woman, 51 years old, never a smoker, overweight from childhood, and obese after the first (and unique) pregnancy. She is currently in menopause from a couple of months, with a tedious menopausal syndrome including flushing, excessive sweat, and hypertension. She has been treated with amlodipine 5 mg in the morning, but she stopped it because of the perception of flushing worsening.
Source